Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

MLA

Nishimoto N, et al. “Treatment of Rheumatoid Arthritis with Humanized Anti-Interleukin-6 Receptor Antibody: A Multicenter, Double-Blind, Placebo-Controlled Trial.” Arthritis & Rheumatism, vol. 50, no. 6, June 2004, pp. 1761–69. EBSCOhost, https://doi.org/10.1002/art.20303.

APA

Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, & Kishimoto T. (2004). Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis & Rheumatism, 50(6), 1761–1769. https://doi.org/10.1002/art.20303

Chicago

Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, and Kishimoto T. 2004. “Treatment of Rheumatoid Arthritis with Humanized Anti-Interleukin-6 Receptor Antibody: A Multicenter, Double-Blind, Placebo-Controlled Trial.” Arthritis & Rheumatism 50 (6): 1761–69. doi:10.1002/art.20303.